FDA Updates ‘Purple Book’ Database
After Recently Transitioning Biologics Lists To Online Data
Executive Summary
The US FDA’s ‘Purple Book’ which was created “to improve transparency and functionality for stakeholders by providing a complete view of biological product options” has been updated after being recently transitioned into an online database.